https://www.news-medical.net/news/20251126/Metformin-fails-to-improve-insulin-resistance-in-type-1-diabetes.aspx
A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged.
No hay comentarios:
Publicar un comentario